The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A systematic review of the literature on gastrointestinal tract amyloidomas: Presentation, management and outcomes.
 
Mariuxi Alexandra Viteri Malone
No Relationships to Disclose
 
Anahat Kaur
No Relationships to Disclose
 
Abhishek Kumar
Stock and Other Ownership Interests - Abbvie; ACADIA Pharmaceuticals; Acadia Pharmaceuticals; ADMA Biologics; Agenus; Agenus; Agenus; AIkido Pharma; Albireo Pharma; Amazon; Amazon; Amgen; Amgen; Amgen; AstraZeneca; AstraZeneca; AVEO; BeyondSpring Pharmaceuticals; BeyondSpring Pharmaceuticals; Bio-Path Holdings; Bio-Path Holdings, Inc; BioTelemetry; Blueprint Medicines; Blueprint Medicines; Bristol-Myers Squibb; Cara Therapeutics; Cara Therapeutics; Cardiff Oncology; Celgene; ChemBio Diagnostic Systems; Contrafect; crispr therapeutics; CryoLife; CUE Biopharma; CVS Health; DermTech; Editas Medicine; Editas Medicine; Five Prime Therapeutics; Five Prime Therapeutics; Geron; Gevo; Globus Medical; Globus Medical; Google; IDEXX Laboratories; IDEXX Laboratories; Immunomedics; Immunomedics; Iovance Biotherapeutics; Iovance Biotherapeutics; Jazz Pharmaceuticals; Johnson & Johnson/Janssen; Kronos; Lilly; Livongo; Medtronic; Northwest Biotherapeutics; Northwest Biotherapeutics; Novavax; Ontrak; Pfizer; Poseida Therapeutics; Precision Biosciences; Precision Biosciences; Protagonist Therapeutics; PTC Therapeutics; PTC Therapeutics; Purple Biotech; Regeneron; Renalytix AI PLC; Schrodinger; Sensei Biotherapeutics; Sierra Oncology; SOC Telemed; SPDR S and P Biotech ETF; Spectrum Pharmaceuticals; Surgalign; Teladoc; Trovagene; Uniqure; VBI Vaccines; Vericel; Vertex; Vertex; Viatris; Viking Therapeutics; Viking Therapeutics